Takeda Sues Teva Over Sleeping Pill ANDA

By Samuel Howard

Law360, New York (November 09, 2009, 2:11 PM ET) -- Takeda Pharmaceutical Co. Ltd. has filed an infringement action to prevent Teva Pharmaceutical Industries Inc. from marketing a generic version of Rozerem, a prescription sleeping medication.

The complaint, lodged Friday in the U.S. District Court for the District of Delaware, alleges Teva is seeking regulatory approval to manufacture and sell a treatment for insomnia that infringes Takeda’s patent rights.

Last month, the defendant notified Takeda that it had submitted an abbreviated new drug application with the U.S. Food and Drug Administration for 8 mg ramelteon tablets,...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles